This is the first report of CIITA deficiency in Morocco, and the variant itself is reported here for the first time worldwide, expanding the genetic spectrum of bare lymphocyte syndrome beyond the well-known North African founder mutation in RFXANK. Here, RFXANK is linked to MHC class II deficiency.